Key result
Neutrophil to platelet ratio emerges as a potential prognostic biomarker in STEMI after primary PCI.
Why the study?
Inflammatory biomarkers are useful for risk stratification in STEMI patients, but a novel index correcting acute inflammation by chronic inflammation status was needed.
Does the neutrophil to platelet ratio (NPR) predict prognosis in STEMI patients undergoing primary PCI?
Observational
Does the neutrophil to platelet ratio (NPR) predict prognosis in STEMI patients undergoing primary PCI?
The neutrophil to platelet ratio (NPR) is proposed as a novel prognostic biomarker in STEMI patients undergoing primary PCI, reflecting both acute and chronic inflammatory status.
Answers are grounded in this paper and cite their sources.
Neutrophil-to-platelet ratio introduction as STEMI biomarker lacks data; leaves open validation before any prognostic role.
Several studies have reported the usefulness of inflammatory biomarkers in risk stratification of ST-elevation myocardial infarction (STEMI) patients.1,2 The majority of STEMI occurs as the result of the formation of a platelet blood clot inside an artery damaged by a chronic inflammatory process (i.e. atherosclerosis). Neutrophils are well known for their role in the setting of infections; they also play a key role in the pathophysiology of STEMI, especially as mediators of acute inflammatory response, probably contributing to microvascular damage and no-reflow phenomenon.3 On the other hand, platelet level in peripheral blood has been found to be dependent on various inflammatory markers (such as C-reactive protein, interleukin 1 and interleukin 6), suggesting that platelets could be a marker of the chronic inflammatory status of the patients, which has been found to be strongly related to atherosclerosis.4 Acute myocardial infarction causes per se a potentially harmful acute inflammatory response,5 which has been evaluated throughout two established inflammatory indexes: neutrophil to lymphocyte ratio and platelet to lymphocyte ratio.2 Our study aimed to assess the prognostic value of a new index, the neutrophil to platelet ratio (NPR), developed with the purpose of correcting the magnitude of the acute inflammatory response (expressed by neutrophils) taking into account the pre-existing chronic inflammation status (expressed by platelets).
No takes yet. Share an insight, caveat, or question.
Somaschini et al. (2019) conducted an observational in ST-elevation myocardial infarction (STEMI). Neutrophil to platelet ratio (NPR) was evaluated. The abstract introduces the neutrophil to platelet ratio as a potential prognostic biomarker in STEMI patients undergoing primary PCI, but reports no quantitative results.
Synapse has enriched 10 related papers. Consider them for comparative context: